Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
January 2015

Vortioxetine (Brintellix): a "Multi-Modal Antidepressant"
The new selective serotonin reuptake inhibitor (SSRI) antidepressant vortioxetine (Brintellix) offers no proven superiority in efficacy or tolerability over older, less expensive, and better tested agents.

Topiramate and Long-term Weight Loss in Schizophrenia Patients
For obese patients with schizophrenia, the anticonvulsant topiramate (Topamax) appears to promote weight loss during treatment and for long after it is discontinued.

In Brief
Paliperidone Palmitate (Invega Sustenna) Approved by FDA for Schizoaffective Disorder; Chronic Marijuana Use Causes Structural Changes in the Brain

Risks of Antipsychotic Drugs in Older Patients
Antipsychotic treatment in elderly patients is associated with an increased risk of mortality and may contribute to acute kidney injury.

Biological Therapies in Psychiatry Newsletter written by Alan J. Gelenberg, MD
For over 30 years,
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders


Concise.
Unbiased.
Informative.

Dr. Alan Gelenberg's Blog
BTP BLOG
Dr. Gelenberg’s thoughts on psychiatry today… and where it’s headed in the future.
BTP Gift Subscriptions
GIFT SUBSCRIPTIONS
Order and receive 3 bonus issues added to your own subscription as our thanks.
Activate Free Online Access for Residents
RESIDENTS: FREE ACCESS
Register now, or if you are completing your residency and received a promotional mailing, enter your code.

Subscribe to BTP
SUBSCRIBE
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
CME Credit
CME CREDIT
Earn 12 Category 1 CME credits for answering questions based on material published in BTP throughout the year.

Dr. Gelenberg invites you to join him in Tucson, AZ the week of February 16, 2015 for the 2015 Update on Psychiatry conference. This 4-day live multi-accredited conference will be held at the JW Marriott Starr Pass. This year's program features outstanding speakers from our University and academic institutions around the country including Dr. Alan Gelenberg. Current clinical practices and research focusing on a variety of psychopharmacology topics will be addressed.

For more information and to register go to www.psychopharm.arizona.edu.

Question please contact Leticia Lovallo at uapsycon@email.arizona.edu or 520.626.1392

BTP Subscriber Quote
"With time as tight as it is, I really appreciate the sheer volume of material that you review and summarize for us. You provide a tremendous service to busy clinicians like me and those we serve. Thanks again!"

- J. Rutherford, M.D.